Lifsey D - Search Results

1

Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin.

Kris MG, Grunberg SM, Gralla RJ, Baltzer L, Zaretsky SA, Lifsey D, Tyson LB, Schmidt L, Hahne WF. Kris MG, et al. Among authors: lifsey d. J Clin Oncol. 1994 May;12(5):1045-9. doi: 10.1200/JCO.1994.12.5.1045. J Clin Oncol. 1994. PMID: 8164028 Clinical Trial.

2

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis.

Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G, Lifsey D, Glaw KC, Stevens BA, Hatfield AK, et al. Rocke LK, et al. Among authors: lifsey d. Cancer. 1993 Oct 1;72(7):2234-8. doi: 10.1002/1097-0142(19931001)72:7<2234::aid-cncr2820720728>3.0.co;2-n. Cancer. 1993. PMID: 8374882 Clinical Trial.

3

Breast Cancer Prevention Trial update.

Facundus M, Lifsey D, Kardinal CG. Facundus M, et al. Among authors: lifsey d. J La State Med Soc. 1993 Apr;145(4):147-9. J La State Med Soc. 1993. PMID: 8486986 Clinical Trial.

4

Cervical cancer screening knowledge, behaviors, and beliefs of Vietnamese women.

Schulmeister L, Lifsey DS. Schulmeister L, et al. Among authors: lifsey ds. Oncol Nurs Forum. 1999 Jun;26(5):879-87. Oncol Nurs Forum. 1999. PMID: 10382186

5

Complexed PSA performance for prostate cancer detection in an African-American population.

Martin B, Cheli CD, Lifsey D, Ward M, Pollard S, Jefferson L, Thiel RP, Rayford W. Martin B, et al. Among authors: lifsey d. Urology. 2003 Nov;62(5):835-9. doi: 10.1016/s0090-4295(03)00675-7. Urology. 2003. PMID: 14624904

6

Statewide analysis of serum prostate specific antigen levels in Louisiana men without prostate cancer.

Kyle C, Ewing T, Wu XC, Mercante D, Lifsey D, Meunier C, Jefferson L, Sartor O, Rayford W. Kyle C, et al. Among authors: lifsey d. J La State Med Soc. 2004 Nov-Dec;156(6):319-23. J La State Med Soc. 2004. PMID: 15688673

7

Knowledge, attitudes and beliefs of women about the importance of prostate cancer screening.

Blanchard K, Proverbs-Singh T, Katner A, Lifsey D, Pollard S, Rayford W. Blanchard K, et al. Among authors: lifsey d. J Natl Med Assoc. 2005 Oct;97(10):1378-85. J Natl Med Assoc. 2005. PMID: 16353659 Free PMC article.

8

Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA).

Martin BJ, Finlay JA, Sterling K, Ward M, Lifsey D, Mercante D, Jainto JM, Martin L, Rayford W. Martin BJ, et al. Among authors: lifsey d. Prostate Cancer Prostatic Dis. 2004;7(2):132-7. doi: 10.1038/sj.pcan.4500706. Prostate Cancer Prostatic Dis. 2004. PMID: 15007379

9

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.

Nakabayashi M, Regan MM, Lifsey D, Kantoff PW, Taplin ME, Sartor O, Oh WK. Nakabayashi M, et al. Among authors: lifsey d. BJU Int. 2005 Oct;96(6):783-6. doi: 10.1111/j.1464-410X.2005.05714.x. BJU Int. 2005. PMID: 16153200

10

Prostate specific antigen isoforms and human glandular kallikrein 2--which offers the best screening performance in a predominantly black population?

Martin BJ, Cheli CD, Sterling K, Ward M, Pollard S, Lifsey D, Mercante D, Martin L, Rayford W. Martin BJ, et al. Among authors: lifsey d. J Urol. 2006 Jan;175(1):104-7. doi: 10.1016/S0022-5347(05)00069-8. J Urol. 2006. PMID: 16406882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters